27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

The Dow Chemical Co.<br />

2030 Willard H. Dow Center<br />

Midland MI 48674, US<br />

Phone: (989) 636-1000; Fax: (989) 636-1830<br />

Web: www.dow.com<br />

KEY PERSONNEL: Andrew N. Liveris; President, CEO and Chairman<br />

Geoffery E. Merszei; Exec. VP and CFO<br />

William F. Banholzer; Corp. VP and CTO<br />

Bill Weideman; VP and Controller<br />

Frank H. Brod; Corp. VP<br />

Heinz Haller; Corp. VP, Strategic Development and New Ventures<br />

Michael R. Gambrell; Exec. VP, Basic Plastics and Chemicals Portfolio<br />

Charles J. Kalil; Corp. VP, General Counsel and Corp. Secretary<br />

David E. Kepler; Sr. VP, Shared Services and Environment, Health and<br />

Safety and CIO<br />

Romeo Kreinberg; Exec. VP, Performance Plastics and Chemicals Portfolio<br />

Julie Fasone Holder; Corp.VP, Human Resources, Diversity and Inclusion<br />

and Public Affairs<br />

Luciano Respini; Corp. VP, Geography<br />

Fernando Ruiz; Corp. VP and Treasurer<br />

Gary R. Veurink; Corp. VP, Manufacturing and Engineering<br />

EMPLOYEES: 42,000 employees<br />

HISTORY: Founded in 1897<br />

Began biotech research in 1979<br />

Acquired United AgriSeeds Inc. (crop biotechnology) for $45M (1987)<br />

Formed joint venture (Dow Elanco & Co.) with Eli Lilly and Co. by combining<br />

their plant-sciences businesses and Dow's industrial pest-control business<br />

(10/89)<br />

Completed $38/share cash tender offer for 58.5M shares of Marion<br />

Laboratories, and acquired 67% of outstanding shares, which finalized<br />

merger to create new company, Marion Merrell Dow (12/89)<br />

Sold the assets from the Biotech Project of CD <strong>Medical</strong> Inc. to UniSyn<br />

Technologies, a wholly owned subsidiary of Synbiotics Corp. (6/90)<br />

Finalized agreement for Hoechst AG to acquire all outstanding shares of<br />

Marion Merrell Dow (2Q95)<br />

Member--Biotechnology Research and Development Corp (BRDC)<br />

Member--Midwest Plant Biotechnology/Consortium<br />

Member--Biotechnology Industry Organization<br />

FACILITIES: 165 manufacturing sites in 37 countries<br />

STOCK-FINANCIAL HISTORY: NYSE--DOW<br />

Net sales $46.307b (YE 05) compared to $40.161b (YE 04)<br />

Net income $4.515b (YE 05) compared to $2.797b (YE 04)<br />

Earnings per share $4.62/share (YE 05) compared to $2.93/share (YE 04)<br />

Average shares outstanding 963.2M (YE 05) compared to 940.1M (YE 04)<br />

Total assets $45.934b (YE 05) compared to $45.885b (YE 04)<br />

SUBSIDIARIES/DIVISIONS: Divisions:<br />

Perfornace Plastics<br />

Performance Chemicals<br />

Plastics<br />

Chemicals<br />

Agricultural Science<br />

Hydrocarbon & Engergy<br />

INVESTMENTS: Collaborative Research, Inc.--$5M, 5% equity<br />

Dow Corning Corp.--joint venture with Corning Inc.<br />

Millipore Corp.--9.5% (1984)<br />

Haeger & Kaessner GmbH--acquired (1986)<br />

United AgriSeeds, Inc.--acquired for $45M (12/87)<br />

Montedison SpA--less than 5%<br />

Copyright ©2006 AHC Media ® 369

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!